# A Study of BV-AVD in People With Bulky Hodgkin Lymphoma

> **NCT06377566** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 71 (estimated)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **DRUG:** Brentuximab vedotin
- **DRUG:** Doxorubicin
- **DRUG:** Vinblastine
- **DRUG:** Dacarbazine
- **DRUG:** Pembrolizumab
- **DRUG:** Gemcitabine
- **DRUG:** Vinorelbine
- **DIAGNOSTIC_TEST:** FDG-PET/CT scan

## Key facts

- **NCT ID:** NCT06377566
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-17
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 71 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06377566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06377566, "A Study of BV-AVD in People With Bulky Hodgkin Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06377566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*